Porcine reproductive and respiratory syndrome virus (PRRSV), one of the most
economically significant pathogens worldwide, has caused numerous outbreaks during the …

Vaccination is the principal means used to control and treat porcine reproductive and
respiratory syndrome virus (PRRSV) infection. An array of PRRS vaccine products is …

Porcine reproductive and respiratory syndrome virus (PRRSV) glycoprotein 5 (GP5) is the
most abundant envelope glycoprotein and a major inducer of neutralizing antibodies in vivo …

Porcine reproductive and respiratory syndrome (PRRS) is an economically devastating viral
disease affecting the swine industry worldwide. The etiological agent, PRRS virus (PRRSV) …

Within a few years of its emergence in the late 1980s, the PRRS virus had spread globally to
become the foremost infectious disease concern for the pork industry. Since 1994, modified …

As with a number of other viruses, Porcine reproductive and respiratory syndrome virus
(PRRSV) has been shown to induce apoptosis, although the mechanism (s) involved remain …

By the end of 2004, the Canadian swine population had experienced a severe increase in
the incidence of Porcine circovirus-associated disease (PCVAD), a problem that was …

In order to determine virulence associated genes in porcine reproductive and respiratory
syndrome virus (PRRSV), a series of chimeric viruses were generated where specific …

The advantages of skin-based vaccination include induction of strong immunity, dose-
sparing, and ease of administration. Several technologies for skin-based immunisation in …

The two major membrane-associated proteins of porcine reproductive and respiratory
syndrome virus (PRRSV), GP5 and M (encoded by ORF5 and ORF6 genes, respectively) …